Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Determine which cash back credit card suits you best. Understand your spending habits to choose the right card for maximum rewards.
26,137 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A new breed of daily-reset covered-call ETFs aims to preserve more upside while delivering monthly income. Here’s how...
Founders Fund's ETHZilla fully liquidates its ether holdings, selling $74.5 million as the crypto market slides. The ...
Tech stocks led a cautious session as AI-driven rally hopes cooled. The Nasdaq Composite retreated while the broader ...
A late-February U.S. intelligence assessment concluded that neither limited air strikes nor a prolonged war would lik...
MARA shares rose about 8% midday as Bitcoin bounced, reviving the long-running debate over whether the crypto miner i...
Global market shifts in 2026 make international exposure a potential anchor for retirement income and diversification...
Uber’s first-quarter results sparked a rare split on Wall Street: Goldman Sachs trims the stock target, while Piper S...
Two affordable small-cap stocks under $15 are drawing retail investors' attention as steady packaged foods demand and...
POET Technologies posted a quarterly miss as a Lumilens deal slows and litigation casts a shadow over growth prospect...
Intel has powered a 492% surge in a year, but a wave of insider selling has traders weighing how durable the rebound ...
A 70-year-old with a $1.2 million portfolio and $30,000 in Social Security faces a tight budget after taxes and healt...